VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q48516853  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235919.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q48516853‏
024 ‎‡a  0000-0002-3997-1328‏ ‎‡2  orcid‏
024 ‎‡a  7101923208‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q48516853‏
046 ‎‡s  19000000‏
100 0 ‎‡a  Renata Rizzo‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Renata Rizzo‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's ADHD and Epilepsy in children with Tourette Syndrome: a triple comorbidity?‏
670 ‎‡a  Author's Aggressive behavior in patients with Sotos syndrome.‏
670 ‎‡a  Author's Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection‏
670 ‎‡a  Author's Association between D18S474 locus on chromosome 18q12 and idiopathic generalized epilepsy‏
670 ‎‡a  Author's Association of adenosine deaminase polymorphism with mild mental retardation.‏
670 ‎‡a  Author's Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.‏
670 ‎‡a  Author's Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants‏
670 ‎‡a  Author's Autosomal dominant and sporadic radio-ulnar synostosis.‏
670 ‎‡a  Author's Autosomal-recessive microcephaly in two siblings, one with normal IQ and both with protruding mandible, small ears, and curved nose.‏
670 ‎‡a  Author's Blink reflex abnormalities in children with Tourette syndrome‏
670 ‎‡a  Author's Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome‏
670 ‎‡a  Author's Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.‏
670 ‎‡a  Author's Clinical correlates of quality of life in Tourette syndrome‏
670 ‎‡a  Author's Clinical manifestations and evaluation of isolated lissencephaly‏
670 ‎‡a  Author's Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome‏
670 ‎‡a  Author's Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism‏
670 ‎‡a  Author's Craniofacial anomalies, severe cerebellar hypoplasia, psychomotor and growth delay in a child with congenital hypothyroidism‏
670 ‎‡a  Author's CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder‏
670 ‎‡a  Author's Disease-specific quality of life in young patients with tourette syndrome‏
670 ‎‡a  Author's Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes‏
670 ‎‡a  Author's DNA repair investigations in nine Italian patients affected by trichothiodystrophy.‏
670 ‎‡a  Author's Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome‏
670 ‎‡a  Author's European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment‏
670 ‎‡a  Author's Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome‏
670 ‎‡a  Author's Familial broad terminal phalanges with one individual showing additional anomalies‏
670 ‎‡a  Author's Febrile and afebrile convulsions: a clinical follow-up‏
670 ‎‡a  Author's Fragile X syndrome associated with tic disorders.‏
670 ‎‡a  Author's Genetic association signal near NTN4 in Tourette syndrome‏
670 ‎‡a  Author's Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents‏
670 ‎‡a  Author's Hemihydranencephaly: living with half brain dysfunction‏
670 ‎‡a  Author's Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy‏
670 ‎‡a  Author's Incidence of Autism Spectrum Disorder in Youths Affected by Gilles de la Tourette Syndrome Based on Data from a Large Single Italian Clinical Cohort‏
670 ‎‡a  Author's Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study‏
670 ‎‡a  Author's Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies‏
670 ‎‡a  Author's Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.‏
670 ‎‡a  Author's Lack of Evidence for Association Between D2S124 and D2S111 Polymorphisms of the SCN2A Gene and Idiopathic Generalized Epilepsy With Generalized Tonic—Clonic Seizures‏
670 ‎‡a  Author's Lateral dermoid cyst of the tongue: case report‏
670 ‎‡a  Author's Long term clinical course of Tourette syndrome‏
670 ‎‡a  Author's Long-term neurological outcome of a sextuplet pregnancy.‏
670 ‎‡a  Author's Long-term outcome of epilepsy in patients with Prader-Willi syndrome.‏
670 ‎‡a  Author's Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs‏
670 ‎‡a  Author's Metabolic Effects of Aripiprazole and Pimozide in Children With Tourette Syndrome‏
670 ‎‡a  Author's Neuropsychological aspects of Tourette syndrome: a review‏
670 ‎‡a  Author's New multiple congenital anomalies: mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement.‏
670 ‎‡a  Author's Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome‏
670 ‎‡a  Author's Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I.‏
670 ‎‡a  Author's Parent and self-report health-related quality of life measures in young patients with Tourette syndrome‏
670 ‎‡a  Author's Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.‏
670 ‎‡a  Author's Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.‏
670 ‎‡a  Author's Primary osteoma cutis — multiple café-au-lait spots and woolly hair anomaly‏
670 ‎‡a  Author's Proximal femoral focal deficiency‏
670 ‎‡a  Author's Proximal femoral focal deficiency (PFFD) and fibular A/hypoplasia (FA/H): a model of a developmental field defect.‏
670 ‎‡a  Author's Quality of life in young people with Tourette syndrome: a controlled study‏
670 ‎‡a  Author's Quality of life in young people with treatment-responsive epilepsy: A controlled study‏
670 ‎‡a  Author's Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome‏
670 ‎‡a  Author's Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families.‏
670 ‎‡a  Author's Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.‏
670 ‎‡a  Author's Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families‏
670 ‎‡a  Author's TBR1is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion‏
670 ‎‡a  Author's The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents‏
670 ‎‡a  Author's The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version.‏
670 ‎‡a  Author's The Kabuki‏
670 ‎‡a  Author's The Kabuki (Niikawa-Kuroki) syndrome: further delineation of the phenotype in 29 non-Japanese patients‏
670 ‎‡a  Author's The perception of time in childhood migraine‏
670 ‎‡a  Author's The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort‏
670 ‎‡a  Author's The successful use of ondansetron in a boy with both leukemia and Tourette syndrome‏
670 ‎‡a  Author's Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings‏
670 ‎‡a  Author's Three Cases of Palatal Tics and Gilles De La Tourette Syndrome‏
670 ‎‡a  Author's Timing recalibration in childhood Tourette syndrome associated with persistent pimozide treatment‏
670 ‎‡a  Author's Tourette syndrome and comorbid ADHD: causes and consequences.‏
670 ‎‡a  Author's Tourette Syndrome and comorbid ADHD: current pharmacological treatment options‏
670 ‎‡a  Author's Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities‏
670 ‎‡a  Author's Tourette syndrome: current data, comorbidities, and therapeutic approach in children‏
909 ‎‡a  (scopus) 7101923208‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000239971328‏ ‎‡9  1‏
919 ‎‡a  qualityoflifeinyoungpeoplewithtourettesyndromeacontrolledstudy‏ ‎‡A  Quality of life in young people with Tourette syndrome: a controlled study‏ ‎‡9  1‏
919 ‎‡a  proximalfemoralfocaldeficiencypffdandfibularahypoplasiafahamodelofadevelopmentalfielddefect‏ ‎‡A  Proximal femoral focal deficiency (PFFD) and fibular A/hypoplasia (FA/H): a model of a developmental field defect.‏ ‎‡9  1‏
919 ‎‡a  proximalfemoralfocaldeficiency‏ ‎‡A  Proximal femoral focal deficiency‏ ‎‡9  1‏
919 ‎‡a  primaryosteomacutismultiplecafeaulaitspotsandwoollyhairanomaly‏ ‎‡A  Primary osteoma cutis — multiple café-au-lait spots and woolly hair anomaly‏ ‎‡9  1‏
919 ‎‡a  pointmutationsthroughoutthegli3genecausegreigcephalopolysyndactylysyndrome‏ ‎‡A  Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.‏ ‎‡9  1‏
919 ‎‡a  persistenceintherapywithrisperidoneandaripiprazoleinpediatricoutpatientsa2yearnaturalisticcomparison‏ ‎‡A  Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.‏ ‎‡9  1‏
919 ‎‡a  parentandselfreporthealthrelatedqualityoflifemeasuresinyoungpatientswithtourettesyndrome‏ ‎‡A  Parent and self-report health-related quality of life measures in young patients with Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  olivopontocerebellaratrophyleadingtorecognitionofcarbohydratedeficientglycoproteinsyndrometype1‏ ‎‡A  Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I.‏ ‎‡9  1‏
919 ‎‡a  oculogyriccrisisarareextrapyramidalsideeffectinthetreatmentoftourettesyndrome‏ ‎‡A  Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  newmultiplecongenitalanomaliesmentalretardationsyndromemcamrwithfaciocutaneousskeletalinvolvement‏ ‎‡A  New multiple congenital anomalies: mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement.‏ ‎‡9  1‏
919 ‎‡a  neuropsychologicalaspectsoftourettesyndromeareview‏ ‎‡A  Neuropsychological aspects of Tourette syndrome: a review‏ ‎‡9  1‏
919 ‎‡a  metaboliceffectsofaripiprazoleandpimozideinchildrenwithtourettesyndrome‏ ‎‡A  Metabolic Effects of Aripiprazole and Pimozide in Children With Tourette Syndrome‏ ‎‡9  1‏
919 ‎‡a  mandatoryelectrocardiographicmonitoringinyoungpatientstreatedwithpsychoactivedrugs‏ ‎‡A  Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs‏ ‎‡9  1‏
919 ‎‡a  longtermoutcomeofepilepsyinpatientswithpraderwillisyndrome‏ ‎‡A  Long-term outcome of epilepsy in patients with Prader-Willi syndrome.‏ ‎‡9  1‏
919 ‎‡a  longtermneurologicaloutcomeofasextupletpregnancy‏ ‎‡A  Long-term neurological outcome of a sextuplet pregnancy.‏ ‎‡9  1‏
919 ‎‡a  longtermclinicalcourseoftourettesyndrome‏ ‎‡A  Long term clinical course of Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  lateraldermoidcystofthetonguecasereport‏ ‎‡A  Lateral dermoid cyst of the tongue: case report‏ ‎‡9  1‏
919 ‎‡a  lackofevidenceforassociationbetweend2s124andd2s111polymorphismsofthescn2ageneandidiopathicgeneralizedepilepsywithgeneralizedtonicclonicseizures‏ ‎‡A  Lack of Evidence for Association Between D2S124 and D2S111 Polymorphisms of the SCN2A Gene and Idiopathic Generalized Epilepsy With Generalized Tonic—Clonic Seizures‏ ‎‡9  1‏
919 ‎‡a  intragenicdeletionsaffecting2alternativetranscriptsoftheimmp2lgeneinpatientswithtourettesyndrome‏ ‎‡A  Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.‏ ‎‡9  1‏
919 ‎‡a  interrogatingthegeneticdeterminantsoftourettessyndromeandotherticdisordersthroughgenomewideassociationstudies‏ ‎‡A  Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies‏ ‎‡9  1‏
919 ‎‡a  increasedantistreptococcalantibodytitersandantibasalgangliaantibodiesinpatientswithtourettesyndromecontrolledcrosssectionalstudy‏ ‎‡A  Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study‏ ‎‡9  1‏
919 ‎‡a  incidenceofautismspectrumdisorderinyouthsaffectedbygillesdelatourettesyndromebasedondatafromalargesingleitalianclinicalcohort‏ ‎‡A  Incidence of Autism Spectrum Disorder in Youths Affected by Gilles de la Tourette Syndrome Based on Data from a Large Single Italian Clinical Cohort‏ ‎‡9  1‏
919 ‎‡a  identificationofc7orf11ttdn1genemutationsandgeneticheterogeneityinnonphotosensitivetrichothiodystrophy‏ ‎‡A  Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy‏ ‎‡9  1‏
919 ‎‡a  hemihydranencephalylivingwithhalfbraindysfunction‏ ‎‡A  Hemihydranencephaly: living with half brain dysfunction‏ ‎‡9  1‏
919 ‎‡a  guanfacineforthetreatmentofattentiondeficithyperactivitydisorderinchildrenandadolescents‏ ‎‡A  Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents‏ ‎‡9  1‏
919 ‎‡a  geneticassociationsignalnearntn4intourettesyndrome‏ ‎‡A  Genetic association signal near NTN4 in Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  fragile10syndromeassociatedwithticdisorders‏ ‎‡A  Fragile X syndrome associated with tic disorders.‏ ‎‡9  1‏
919 ‎‡a  febrileandafebrileconvulsionsaclinicalfollowup‏ ‎‡A  Febrile and afebrile convulsions: a clinical follow-up‏ ‎‡9  1‏
919 ‎‡a  familialbroadterminalphalangeswith1individualshowingadditionalanomalies‏ ‎‡A  Familial broad terminal phalanges with one individual showing additional anomalies‏ ‎‡9  1‏
919 ‎‡a  evaluationofthelimhomeoboxgeneslhx6andlhx8ascandidatesfortourettesyndrome‏ ‎‡A  Evaluation of the LIM homeobox genes LHX6 and LHX8 as candidates for Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  europeanclinicalguidelinesfortourettesyndromeandotherticdisorderspart1assessment‏ ‎‡A  European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment‏ ‎‡9  1‏
919 ‎‡a  erratumtolongtermoutcomeofepilepsyinpatientswithpraderwillisyndrome‏ ‎‡A  Erratum to: Long-term outcome of epilepsy in patients with Prader–Willi syndrome‏ ‎‡9  1‏
919 ‎‡a  dnarepairinvestigationsin9italianpatientsaffectedbytrichothiodystrophy‏ ‎‡A  DNA repair investigations in nine Italian patients affected by trichothiodystrophy.‏ ‎‡9  1‏
919 ‎‡a  disentanglingtheeffectsoftourettesyndromeandattentiondeficithyperactivitydisorderoncognitiveandbehavioralphenotypes‏ ‎‡A  Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes‏ ‎‡9  1‏
919 ‎‡a  diseasespecificqualityoflifeinyoungpatientswithtourettesyndrome‏ ‎‡A  Disease-specific quality of life in young patients with tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  csfnglycanprofilerevealssialylationdeficiencyinapatientwithgm2gangliosidosispresentingaschildhooddisintegrativedisorder‏ ‎‡A  CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder‏ ‎‡9  1‏
919 ‎‡a  craniofacialanomaliesseverecerebellarhypoplasiapsychomotorandgrowthdelayinachildwithcongenitalhypothyroidism‏ ‎‡A  Craniofacial anomalies, severe cerebellar hypoplasia, psychomotor and growth delay in a child with congenital hypothyroidism‏ ‎‡9  1‏
919 ‎‡a  convulsivedisorderandgeneticpolymorphismassociationofidiopathicgeneralizedepilepsywithhaptoglobinpolymorphism‏ ‎‡A  Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism‏ ‎‡9  1‏
919 ‎‡a  clinicalpharmacologyofcomorbidattentiondeficithyperactivitydisorderintourettesyndrome‏ ‎‡A  Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  clinicalmanifestationsandevaluationofisolatedlissencephaly‏ ‎‡A  Clinical manifestations and evaluation of isolated lissencephaly‏ ‎‡9  1‏
919 ‎‡a  clinicalcorrelatesofqualityoflifeintourettesyndrome‏ ‎‡A  Clinical correlates of quality of life in Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  circulatingmirnasprofilesintourettesyndromemoleculardataandclinicalimplications‏ ‎‡A  Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.‏ ‎‡9  1‏
919 ‎‡a  cardiovascularsafetyofaripiprazoleandpimozideinyoungpatientswithtourettesyndrome‏ ‎‡A  Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  blinkreflexabnormalitiesinchildrenwithtourettesyndrome‏ ‎‡A  Blink reflex abnormalities in children with Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  autosomalrecessivemicrocephalyin2siblings1withnormaliqandbothwithprotrudingmandiblesmallearsandcurvednose‏ ‎‡A  Autosomal-recessive microcephaly in two siblings, one with normal IQ and both with protruding mandible, small ears, and curved nose.‏ ‎‡9  1‏
919 ‎‡a  autosomaldominantandsporadicradioulnarsynostosis‏ ‎‡A  Autosomal dominant and sporadic radio-ulnar synostosis.‏ ‎‡9  1‏
919 ‎‡a  autoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionsydenhamchoreapandasandpandasvariants‏ ‎‡A  Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants‏ ‎‡9  1‏
919 ‎‡a  associationoftrp53polymorphicvariantsatcodon72withnonsyndromicmentalretardation‏ ‎‡A  Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.‏ ‎‡9  1‏
919 ‎‡a  associationofadenosinedeaminasepolymorphismwithmildmentalretardation‏ ‎‡A  Association of adenosine deaminase polymorphism with mild mental retardation.‏ ‎‡9  1‏
919 ‎‡a  associationbetweend18s474locusonchromosome18q12andidiopathicgeneralizedepilepsy‏ ‎‡A  Association between D18S474 locus on chromosome 18q12 and idiopathic generalized epilepsy‏ ‎‡9  1‏
919 ‎‡a  antibrainantibodiesinpandasversusuncomplicatedstreptococcalinfection‏ ‎‡A  Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection‏ ‎‡9  1‏
919 ‎‡a  aggressivebehaviorinpatientswithsotossyndrome‏ ‎‡A  Aggressive behavior in patients with Sotos syndrome.‏ ‎‡9  1‏
919 ‎‡a  adhdandepilepsyinchildrenwithtourettesyndromeatriplecomorbidity‏ ‎‡A  ADHD and Epilepsy in children with Tourette Syndrome: a triple comorbidity?‏ ‎‡9  1‏
919 ‎‡a  tourettesyndromeandcomorbidadhdcausesandconsequences‏ ‎‡A  Tourette syndrome and comorbid ADHD: causes and consequences.‏ ‎‡9  1‏
919 ‎‡a  tourettesyndromeandcomorbidadhdcurrentpharmacologicaltreatmentoptions‏ ‎‡A  Tourette Syndrome and comorbid ADHD: current pharmacological treatment options‏ ‎‡9  1‏
919 ‎‡a  tourettesyndromeandcomorbidconditionsaspectrumofdifferentseveritiesandcomplexities‏ ‎‡A  Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities‏ ‎‡9  1‏
919 ‎‡a  tourettesyndromecurrentdatacomorbiditiesandtherapeuticapproachinchildren‏ ‎‡A  Tourette syndrome: current data, comorbidities, and therapeutic approach in children‏ ‎‡9  1‏
919 ‎‡a  timingrecalibrationinchildhoodtourettesyndromeassociatedwithpersistentpimozidetreatment‏ ‎‡A  Timing recalibration in childhood Tourette syndrome associated with persistent pimozide treatment‏ ‎‡9  1‏
919 ‎‡a  3casesofpalatalticsandgillesdelatourettesyndrome‏ ‎‡A  Three Cases of Palatal Tics and Gilles De La Tourette Syndrome‏ ‎‡9  1‏
919 ‎‡a  therapeuticdrugmonitoringof2generationantipsychoticsinpediatricpatientsanobservationalstudyinreallifesettings‏ ‎‡A  Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings‏ ‎‡9  1‏
919 ‎‡a  successfuluseofondansetroninaboywithbothleukemiaandtourettesyndrome‏ ‎‡A  The successful use of ondansetron in a boy with both leukemia and Tourette syndrome‏ ‎‡9  1‏
919 ‎‡a  relationshipbetweengroupastreptococcalinfectionsandtourettesyndromeastudyonalargeservicebasedcohort‏ ‎‡A  The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort‏ ‎‡9  1‏
919 ‎‡a  perceptionoftimeinchildhoodmigraine‏ ‎‡A  The perception of time in childhood migraine‏ ‎‡9  1‏
919 ‎‡a  kabukiniikawakurokisyndromefurtherdelineationofthephenotypein29nonjapanesepatients‏ ‎‡A  The Kabuki (Niikawa-Kuroki) syndrome: further delineation of the phenotype in 29 non-Japanese patients‏ ‎‡9  1‏
919 ‎‡a  kabuki‏ ‎‡A  The Kabuki‏ ‎‡9  1‏
919 ‎‡a  gillesdelatourettesyndromequalityoflifescaleforchildrenandadolescentsc&agtsqoldevelopmentandvalidationoftheitalianversion‏ ‎‡A  The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version.‏ ‎‡9  1‏
919 ‎‡a  gillesdelatourettesyndromequalityoflifescaleforchildrenandadolescents‏ ‎‡A  The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents‏ ‎‡9  1‏
919 ‎‡a  tbr1isthecandidategeneforintellectualdisabilityinpatientswitha2q242interstitialdeletion‏ ‎‡A  TBR1is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion‏ ‎‡9  1‏
919 ‎‡a  supportofthehistaminergichypothesisintourettesyndromeassociationofthehistaminedecarboxylasegeneinalargesampleoffamilies‏ ‎‡A  Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families‏ ‎‡9  1‏
919 ‎‡a  2generationantipsychoticsinreallifepaediatricpatientsadversedrugreactionsandclinicaloutcomesofdrugswitch‏ ‎‡A  Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.‏ ‎‡9  1‏
919 ‎‡a  replicationofassociationbetweenaslitrk1haplotypeandtourettesyndromeinalargesampleoffamilies‏ ‎‡A  Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families.‏ ‎‡9  1‏
919 ‎‡a  rarecopynumbervariantsinnrxn1andcntn6increaseriskfortourettesyndrome‏ ‎‡A  Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome‏ ‎‡9  1‏
919 ‎‡a  qualityoflifeinyoungpeoplewithtreatmentresponsiveepilepsyacontrolledstudy‏ ‎‡A  Quality of life in young people with treatment-responsive epilepsy: A controlled study‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
996 ‎‡2  NUKAT|n 2020210043‏
996 ‎‡2  BAV|495_315813‏
997 ‎‡a  1900 0 flourished 0000 0‏ ‎‡9  1‏